Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
* Correspondence: Li Wang, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Also, women in midlife may have other health concerns alongside weight, such as bone health, cardiovascular health, and loss of muscle, which could affect how they respond to GLP-1s
They are most common in the first two weeks and usually resolve with adaptation
GLP-1 medications support meaningful weight loss when paired with provider-guided dosing, adherence, and behavior change
The US FDA has warned against using such drugs, like semaglutide or tirzepatide, as they are not evaluated for safety, quality, or efficacy
A combination of responsible clinical programs and technology is needed to provide better access to GLP-1s for appropriate uses
